Neuberger Berman Group LLC Tg Therapeutics, Inc. Transaction History
Neuberger Berman Group LLC
- $124 Billion
- Q2 2025
A detailed history of Neuberger Berman Group LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 8,076 shares of TGTX stock, worth $274,745. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,076
Previous 8,076
-0.0%
Holding current value
$274,745
Previous $290,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
407Shares Held
91.7MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.8MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$387 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$259 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$119 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$104 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.94B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...